Latest Insider Transactions at Regeneron Pharmaceuticals, Inc. (REGN)
This section provides a real-time view of insider transactions for Regeneron Pharmaceuticals, Inc. (REGN). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of REGENERON PHARMACEUTICALS, INC. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of REGENERON PHARMACEUTICALS, INC.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 04
2022
|
Arthur F Ryan Director |
SELL
Open market or private sale
|
Direct |
10,453
-15.31%
|
$6,491,313
$621.48 P/Share
|
|
Aug 04
2022
|
Arthur F Ryan Director |
BUY
Exercise of conversion of derivative security
|
Direct |
10,453
+13.34%
|
$4,306,636
$412.58 P/Share
|
|
Aug 04
2022
|
Arthur F Ryan Director |
SELL
Bona fide gift
|
Direct |
2,500
-11.27%
|
-
|
|
Aug 04
2022
|
Neil Stahl EVP Research and Development |
SELL
Payment of exercise price or tax liability
|
Direct |
71,218
-48.19%
|
$43,656,634
$613.0 P/Share
|
|
Aug 04
2022
|
Neil Stahl EVP Research and Development |
BUY
Exercise of conversion of derivative security
|
Direct |
95,000
+39.13%
|
$25,650,000
$270.43 P/Share
|
|
Aug 01
2022
|
Marion Mc Court EVP Commercial |
SELL
Open market or private sale
|
Direct |
1,100
-5.3%
|
$639,100
$581.53 P/Share
|
|
Aug 01
2022
|
Marion Mc Court EVP Commercial |
BUY
Exercise of conversion of derivative security
|
Direct |
1,100
+5.04%
|
$376,200
$342.93 P/Share
|
|
Jul 05
2022
|
P Roy Vagelos Director |
SELL
Bona fide gift
|
Indirect |
357
-0.28%
|
-
|
|
Jul 01
2022
|
Marion Mc Court EVP Commercial |
SELL
Open market or private sale
|
Direct |
1,100
-5.3%
|
$645,700
$587.76 P/Share
|
|
Jul 01
2022
|
Marion Mc Court EVP Commercial |
BUY
Exercise of conversion of derivative security
|
Direct |
1,100
+5.04%
|
$376,200
$342.93 P/Share
|
|
Jun 01
2022
|
Marion Mc Court EVP Commercial |
SELL
Open market or private sale
|
Direct |
1,100
-5.3%
|
$735,900
$669.51 P/Share
|
|
Jun 01
2022
|
Marion Mc Court EVP Commercial |
BUY
Exercise of conversion of derivative security
|
Direct |
1,100
+5.04%
|
$376,200
$342.93 P/Share
|
|
May 24
2022
|
P Roy Vagelos Director |
SELL
Bona fide gift
|
Direct |
23,077
-6.68%
|
-
|
|
May 17
2022
|
Andrew J Murphy EVP Research |
SELL
Open market or private sale
|
Direct |
3,543
-0.39%
|
$2,349,009
$663.18 P/Share
|
|
May 16
2022
|
Andrew J Murphy EVP Research |
SELL
Payment of exercise price or tax liability
|
Direct |
6,457
-9.43%
|
$4,184,136
$648.31 P/Share
|
|
May 16
2022
|
Andrew J Murphy EVP Research |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+12.74%
|
$1,790,000
$179.13 P/Share
|
|
May 02
2022
|
Marion Mc Court EVP Commercial |
SELL
Open market or private sale
|
Direct |
1,100
-5.3%
|
$721,600
$656.97 P/Share
|
|
May 02
2022
|
Marion Mc Court EVP Commercial |
BUY
Exercise of conversion of derivative security
|
Direct |
1,100
+5.04%
|
$376,200
$342.93 P/Share
|
|
May 02
2022
|
Arthur F Ryan Director |
SELL
Open market or private sale
|
Direct |
100
-0.03%
|
$65,000
$650.58 P/Share
|
|
Apr 11
2022
|
Robert E Landry EVP Finance CFO |
SELL
Open market or private sale
|
Direct |
1,862
-0.69%
|
$1,366,708
$734.5 P/Share
|
|
Apr 08
2022
|
Christopher R. Fenimore SVP Finance & CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
5,606
-9.7%
|
$4,126,016
$736.21 P/Share
|
|
Apr 08
2022
|
Christopher R. Fenimore SVP Finance & CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
7,450
+11.26%
|
$3,076,850
$413.05 P/Share
|
|
Apr 08
2022
|
Robert E Landry EVP Finance CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
6,138
-9.01%
|
$4,517,568
$736.21 P/Share
|
|
Apr 08
2022
|
Robert E Landry EVP Finance CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
8,000
+10.29%
|
$3,120,000
$390.79 P/Share
|
|
Apr 08
2022
|
Robert E Landry EVP Finance CFO |
SELL
Open market or private sale
|
Direct |
325
-0.11%
|
$239,200
$736.48 P/Share
|
|
Apr 07
2022
|
Bonnie L Bassler Director |
SELL
Open market or private sale
|
Direct |
1,240
-53.4%
|
$899,000
$725.0 P/Share
|
|
Apr 07
2022
|
Bonnie L Bassler Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,240
+34.81%
|
$471,200
$380.95 P/Share
|
|
Apr 07
2022
|
Joseph J Larosa EVP General Counsel and Secret |
SELL
Open market or private sale
|
Direct |
5,114
-23.23%
|
$3,687,194
$721.1 P/Share
|
|
Apr 07
2022
|
Robert E Landry EVP Finance CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,175
-3.89%
|
$841,300
$716.09 P/Share
|
|
Apr 07
2022
|
Robert E Landry EVP Finance CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
1,500
+4.73%
|
$598,500
$399.66 P/Share
|
|
Apr 06
2022
|
P Roy Vagelos Director |
SELL
Bona fide gift
|
Indirect |
302
-0.24%
|
-
|
|
Apr 06
2022
|
Leonard S Schleifer Bd. Co-Chair, President & CEO |
SELL
Open market or private sale
|
Indirect |
2,653
-19.18%
|
$1,883,630
$710.04 P/Share
|
|
Apr 05
2022
|
Leonard S Schleifer Bd. Co-Chair, President & CEO |
SELL
Open market or private sale
|
Indirect |
4,461
-24.39%
|
$3,167,310
$710.05 P/Share
|
|
Apr 01
2022
|
Arthur F Ryan Director |
SELL
Open market or private sale
|
Direct |
100
-0.03%
|
$69,300
$693.17 P/Share
|
|
Apr 01
2022
|
Joseph J Larosa EVP General Counsel and Secret |
SELL
Open market or private sale
|
Direct |
5,114
-1.38%
|
$3,538,888
$692.65 P/Share
|
|
Apr 01
2022
|
Marion Mc Court EVP Commercial |
SELL
Open market or private sale
|
Direct |
1,000
-4.84%
|
$701,000
$701.82 P/Share
|
|
Apr 01
2022
|
Marion Mc Court EVP Commercial |
BUY
Exercise of conversion of derivative security
|
Direct |
1,000
+4.62%
|
$342,000
$342.93 P/Share
|
|
Apr 01
2022
|
Robert E Landry EVP Finance CFO |
SELL
Open market or private sale
|
Direct |
316
-0.54%
|
$220,568
$698.74 P/Share
|
|
Mar 31
2022
|
Leonard S Schleifer Bd. Co-Chair, President & CEO |
SELL
Open market or private sale
|
Indirect |
2,886
-13.63%
|
$2,049,060
$710.01 P/Share
|
|
Mar 31
2022
|
Robert E Landry EVP Finance CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,184
-3.91%
|
$828,800
$700.99 P/Share
|
|
Mar 31
2022
|
Robert E Landry EVP Finance CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
1,500
+4.73%
|
$598,500
$399.66 P/Share
|
|
Mar 31
2022
|
Christopher R. Fenimore SVP Finance & CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
8,654
-14.68%
|
$6,057,800
$700.99 P/Share
|
|
Mar 31
2022
|
Christopher R. Fenimore SVP Finance & CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
12,000
+15.94%
|
$4,956,000
$413.05 P/Share
|
|
Mar 30
2022
|
Bonnie L Bassler Director |
SELL
Open market or private sale
|
Direct |
1,240
-53.4%
|
$868,000
$700.0 P/Share
|
|
Mar 30
2022
|
Bonnie L Bassler Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,240
+34.81%
|
$471,200
$380.95 P/Share
|
|
Mar 30
2022
|
P Roy Vagelos Director |
SELL
Open market or private sale
|
Indirect |
28,572
-23.98%
|
$20,000,400
$700.01 P/Share
|
|
Mar 30
2022
|
Joseph L Goldstein Director |
SELL
Open market or private sale
|
Direct |
2,431
-28.56%
|
$1,701,700
$700.0 P/Share
|
|
Mar 30
2022
|
Joseph L Goldstein Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,431
+22.21%
|
$909,194
$374.12 P/Share
|
|
Mar 30
2022
|
Michael S Brown Director |
SELL
Open market or private sale
|
Direct |
408
-27.38%
|
$285,192
$699.0 P/Share
|
|
Mar 30
2022
|
Michael S Brown Director |
BUY
Exercise of conversion of derivative security
|
Direct |
408
+21.5%
|
$152,592
$374.12 P/Share
|